Merrill Lynch Pharmaceutical Holders ETF  

(Public, NYSEARCA:PPH)   Watch this stock  
Find more results for PPH
60.67
+0.08 (0.13%)
Aug 1 - Close
NYSEARCA real-time data - Disclaimer
Currency in USD
Range 60.29 - 60.86
52 week 15.14 - 60.86
Open 60.41
Vol. 22,667.00
Mkt cap 317.37M
P/E     -
Div/yield     -/1.70
EPS     -
Shares 6.81M
Beta     -
Inst. own     -

Address

C/O THE BANK OF NEW YORK 101 BARCLAY ST. 22-W
NEW YORK, NY 10286
United States - Map
+1-212-8152213 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Market Vectors Pharmaceutical ETF , formerly The Pharmaceutical HOLDRS Trust, issues depositary receipts called Pharmaceutical HOLDRS, representing an undivided beneficial ownership in the United States-traded common stock of a group of specified companies that are involved in various segments of the pharmaceutical industry. The Bank of New York is the trustee. The Pharmaceutical HOLDRS Trust was formed under a depositary trust agreement dated January 24, 2000. The 21 issuers of the underlying securities represented by a Pharmaceutical HOLDR, as of August 1, 2005, were Abbott Laboratories, Andrx Corp Del, Allergan, Inc., Bristol-Myers Squibb Company, Biovail Corp, Advanced Medical Optics Inc, Forest Laboratories, Inc., Hospira Inc, IVAX Corporation, Johnson & Johnson, King Pharmaceuticals Inc, Eli Lilly and Company, Medco Health Solutions Inc., Merck & Co., Inc., Milan Laboratories Inc. and Wyeth and Zimmer Holdings, Inc.